Loading patent…
OwnerWolfgang Wuttke, Hubertus Jarry +3inventors
InventorsWolfgang Wuttke, Hubertus Jarry, Michael Popp, Volker Christoffel, Barbara Spengler
Estimating the term…
The present invention relates to extracts from the lridaceae plant Belamcanda chinensis for producing a ready-formulated medicament suited for the selective treatment and/or prophylaxis of sexual hormone-related disorders of the uro-genital tract. The inventive extracts are moreover suited for the treatment and/or prophylaxis of post-menopausal bladder infections and of urinary incontinence. The are moreover indicated for the treatment of benign and malignant prostate hyperplasies. It was moreover found that the ingredient tectorigenin as well as its glycosides, isolated from Belamcanda chinensis, essentially has the same effects as the whole extract.
Use of extracts from Belamcanda chinensis for producing an estrogen-type, organoselective medicament having no uterotrophic effect or one that is at least negligible,
Use of extracts from Belamcanda chinensis for producing an estrogen-type, organoselective medicament,
Use of tectorigenin and/or its glycosides and/or extracts containing tectorigenin and/or tectorigenin glycoside(s) for producing an estrogen-type, organoselective medicament,
Use of tectorigenin and/or its glycosides and/or extracts containing tectorigenin and/or tectorigenin glycoside(s) for producing an estrogen-type, organoselective medicament having no uterotrophic effect or one that is at least negligible,
Dependencies are inferred from the claim text.